Skip to main content
main-content

Type 2 diabetes

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Expert opinion editorial

Nutrition therapy for diabetes: A marathon, not a sprint

Nutrition therapy for diabetes: A marathon, not a sprint

What's new in the 2019 update to the ADA guidelines on nutrition therapy for adults with diabetes or prediabetes? Diabetes Educator Amy Hess Fischl explains [read more].

Get more on:  Diet and nutritional management

medwireNews top story

Metabolic surgery may improve cardiovascular prognosis in type 2 diabetes

Obesity surgery

People with type 2 diabetes and obesity who undergo metabolic surgery have a significantly lower risk for major adverse cardiovascular events than those who do not receive surgery, observational study data show.

medwireNews top story

Meta-analysis demonstrates cardioprotective effect of GLP-1 receptor agonists

Heart and stethoscope

Treatment with glucagon-like peptide receptor agonists reduces the risk for major adverse cardiovascular events among people with type 2 diabetes, indicate findings from a large meta-analysis.

Ask the expert video

Which diets can I safely recommend to patients with type 2 diabetes?

Liz Morris and Pam Dyson

WATCH | Research Dietitian Pam Dyson and General Practitioner Liz Morris discuss evidence-based dietary recommendations for the management of type 2 diabetes.

Get more on: Diet, and nutritional management | Type 2 diabetes

medwireNews top story

Bariatric surgery linked to late adverse events

Gastric bypass surgery (used with permission)

People who undergo bariatric surgery have a lower long-term risk for mortality, but a higher risk for adverse events such as gastrointestinal and nutritional disorders, compared with those who do not undergo surgery, researchers report.

Expert opinion editorial

Cardiorenal syndromes and SGLT2 inhibitor usage

Cardiorenal syndromes and SGLT2 inhibitor usage

Sanjay Kalra explores the intrinsic link between the cardiovascular and renal systems, focusing on whether the SGLT2 inhibitor class has a role to play in diabetic patients with cardiorenal comorbidity [read more].

Get more on: SGLT2 inhibitors | Nephropathy | Cardiovascular disease 

medwireNews top story

Support for metformin cardioprotective effect

Heartbeat

Findings from the SAVOR-TIMI 53 trial suggest that metformin treatment reduces cardiovascular and all-cause mortality but not nonfatal cardiovascular disease events, but a meta-analysis points to wider benefits.

medwireNews top story

Real-world data reassure on severe UTI risk with SGLT2 inhibition

Urine test strip

The risk for severe urinary tract infections among people with type 2 diabetes in the real-world setting may be no greater with use of sodium-glucose cotransporter 2 inhibitors than with other modern antidiabetes medications, research suggests.

medwireNews feature

Adaptive and flexible: Closed-loop technology for all

Roman Hovorka

medwireNews talks to one of the pioneers of closed-loop insulin delivery, Roman Hovorka, about his algorithm, his research so far, and his plans for commercialization.

medwireNews top story

Diabetes-associated heart failure risk greatest in women

Heart and stethoscope

Diabetes is a stronger risk factor for heart failure among women compared with men, indicate the results of a large systematic review and meta-analysis.

medwireNews top story

CGM measures have variable correlation with HbA1c

HbA1c

Glycated hemoglobin levels correlate strongly with continuous glucose monitoring-measured average blood glucose and hyperglycemia, but poorly with hypoglycemia, say researchers.

medwireNews top story

Holistic approach can shorten diabetes inpatient stays

Dice

A nurse-delivered care program based on a whole-systems approach can lead to shorter hospital stays for patients with diabetes, UK researchers report.

medwireNews top story

General population underestimates type 2 diabetes risk

Graph

People in the general population typically believe that they have a low risk for type 2 diabetes, regardless of what their actual risk is, show the results of a German national survey focusing on diabetes-related knowledge.

medwireNews feature

Fournier gangrene: A challenge for risk–benefit communication

Doctor patient consultation

The recent postmarketing data on Fournier gangrene in people taking sodium-glucose cotransporter 2 inhibitors has increased concerns about this very rare but potentially fatal side effect. medwireNews talks to primary care diabetes specialist Kevin Fernando about how the findings affect risk–benefit considerations.

medwireNews top story

Dapagliflozin renoprotective in diabetes patients with preserved kidney function

Kidneys

Detailed analysis of renal outcomes in the DECLARE-TIMI 58 trial confirms that treatment with the sodium-glucose cotransporter 2 inhibitor dapagliflozin is renoprotective in patients with type 2 diabetes and preserved kidney function.

The REWIND trial

Cardiovascular disease (illustration)
ADA 2019

The DUAL VIII trial

Insulin pens
ADA 2019

The PIONEER trials

diabetes_pills_syringe
ADA 2019

Today2 trial

Heart health monitor
ADA 2019

The D2d trial

Vitamin D pills

09-10-2019 | Diet | Editorial | Article

Nutrition therapy for diabetes: A marathon, not a sprint

A brief review of the 2019 ADA consensus report on nutrition therapy for adults with diabetes or prediabetes

What's new in the 2019 update to the ADA guidelines on nutrition therapy for adults with diabetes or prediabetes? Diabetes Educator Amy Hess Fischl explains.

08-28-2019 | Diet | Video | Article

Nutrition recommendations for type 2 diabetes: What's changed?

WATCH | Research Dietitian Pam Dyson and General Practitioner Liz Morris discuss how improvements in nutrition science have impacted guidance around low-glycemic index diets and carbohydrate intake (2:43).

08-21-2019 | Diet | Video | Article

Are these popular diets safe for your patients with type 2 diabetes?

WATCH | Egg diets? Alkaline diets? Raspberry ketones? Pam Dyson and Liz Morris discuss how to handle your patients' questions about these dietary approaches and more (5:13).

Diagnosis and management of prediabetes: a consensus of GCC countries

Guidance based on outcomes of an advisory board of diabetes experts, for healthcare professionals addressing the diagnosis and treatment of prediabetes.

This interactive roadmap is intended for healthcare professionals practicing in Saudi Arabia, Kuwait, the United Arab Emirates, Qatar, Bahrain, and Oman. 

Funding for this roadmap was provided by Merck Serono Middle East FZ-LLC

Access the interactive roadmap

Downloadable slides

10-31-2018 | Slideset | Collection

FreeStyle Libre collection

These slide sets summarize the results of randomized controlled trials investigating the use of flash glucose-sensing technology in patients with diabetes.

Funded by an educational grant from Abbott Diabetes Care

Themed collections

06-25-2018 | SGLT2 inhibitors | Themed collection | Collection

Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes

An updated collection of articles focusing on the mechanism of action and clinical use of sodium-glucose cotransporter-2 inhibitors in patients with diabetes.

Journal articles and book chapters

Guidelines

A convenient single access point, providing diabetes professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Slides

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

Practice tips

Practical information, guidance, and helpful resources for diabetes healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within diabetes management, as recommended by our Editorial Board.

Independent Medical Education

Educational programs building upon the most current research and professional practice recommendations, with the aim of enabling more efficient diagnosis, optimizing treatment, and improving patient outcomes.

ADVERTISEMENT

Flash glucose monitoring technology

Downloadable slide sets from key clinical trials in people with diabetes

Image Credits